logo
  

GE Agrees To Offer Terms For European Sponsor Finance - Quick Facts

General Electric Company (GE) announced that Sumitomo Mitsui Banking Corporation Europe Limited, a wholly owned subsidiary of Sumitomo Mitsui Banking Corporation, has made an agreed offer to acquire GE's European Sponsor Finance business for approximately $2.2 billion. The business is a provider of sponsor finance for European mid-market, private-equity backed transactions.

The company announced that the sale of its Appliances business to Electrolux will not close during the second quarter of the current year. Electrolux and GE continue to work actively with the Department of Justice to endeavor to resolve the remaining items in the clearance process, with the goal of closing the deal in 2015. GE expects an approximate after-tax gain of $0.05-$0.07 per share at closing.

General Electric also announced that it will book a $0.03 per share gain in the second quarter as part of an early settlement related to obligations entered into in the initial NBCUniversal joint venture with Comcast, which was announced in 2011. As a result, GE expects gains to offset restructuring and other charges during the second quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT